Arbutus Biopharma Corp (ABUS) — Capital Reinvestment Ratio
Latest as of March 2022:
0.00x
Arbutus Biopharma Corp (ABUS) has a Capital Reinvestment Ratio of 0.00x as of March 2022, meaning it reinvests 0% of its operating cash flow ($20.62 Million) in capital expenditures ($75.00K). See cash generation quality of Arbutus Biopharma Corp to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$20.62 Million
USD
Capital Expenditures
$75.00K
USD
Data as of
Mar 2022
Most recent filing
Arbutus Biopharma Corp Capital Reinvestment Ratio (2012–2012)
This chart tracks Arbutus Biopharma Corp's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Arbutus Biopharma Corp (2012–2012)
Year-by-year Capital Reinvestment Ratio for Arbutus Biopharma Corp from 2012 to 2012. For live market cap and broader valuation context, see ABUS market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2012 | 0.00x | $33.27 Million | $14.90K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow